Literature DB >> 26045509

Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL).

Tim Ra van den Heuvel1,2, Daisy M Jonkers1,2, Steven Fg Jeuring1,2, Marielle Jl Romberg-Camps3, Liekele E Oostenbrug4, Maurice P Zeegers2, Ad A Masclee1,2, Marie J Pierik1,2.   

Abstract

Keywords:  Crohn's disease; Inflammatory bowel disease; biobank; cohort; epidemiology; molecular epidemiology; population based; ulcerative colitis

Mesh：

Year:  2017        PMID： 26045509     DOI： 10.1093/ije/dyv088

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  19 in total

1.  Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.

Authors:  Steven F G Jeuring; Vince B C Biemans; Tim R A van den Heuvel; Maurice P Zeegers; Wim H Hameeteman; Mariëlle J L Romberg-Camps; Liekele E Oostenbrug; Ad A M Masclee; Daisy M A E Jonkers; Marieke J Pierik
Journal:  Am J Gastroenterol       Date:  2018-01-09       Impact factor: 10.864

2.  Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.

Authors:  Steven F G Jeuring; Tim R A van den Heuvel; Limmie Y L Liu; Maurice P Zeegers; Wim H Hameeteman; Mariëlle J L Romberg-Camps; Liekele E Oostenbrug; Ad A M Masclee; Daisy M A E Jonkers; Marieke J Pierik
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

Review 3.  Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn's disease.

Authors:  C X W Tan; H S Brand; N K H de Boer; T Forouzanfar
Journal:  Br Dent J       Date:  2016-12-16       Impact factor: 1.626

Review 4.  The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review.

Authors:  Thomas K Wiersma; Marijn C Visschedijk; Nanne K de Boer; Marjolijn N Lub-de Hooge; Jelmer R Prins; Daan J Touw; Paola Mian
Journal:  Pharmaceutics       Date:  2022-06-11       Impact factor: 6.525

5.  Better survival of renal cell carcinoma in patients with inflammatory bowel disease.

Authors:  Lauranne A A P Derikx; Loes H C Nissen; Joost P H Drenth; Carla M van Herpen; Wietske Kievit; Rob H A Verhoeven; Peter F A Mulders; Christina A Hulsbergen-van de Kaa; Marye J Boers-Sonderen; Tim R A van den Heuvel; Marieke Pierik; Iris D Nagtegaal; Frank Hoentjen
Journal:  Oncotarget       Date:  2015-11-10

6.  The fecal microbiota as a biomarker for disease activity in Crohn's disease.

Authors:  Danyta I Tedjo; Agnieszka Smolinska; Paul H Savelkoul; Ad A Masclee; Frederik J van Schooten; Marieke J Pierik; John Penders; Daisy M A E Jonkers
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

Review 7.  Factors Promoting Development of Fibrosis in Crohn's Disease.

Authors:  Gerhard Rogler; Martin Hausmann
Journal:  Front Med (Lausanne)       Date:  2017-07-07

8.  Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Authors:  Berrie Meijer; Margien L Seinen; Remco van Egmond; Gerd Bouma; Chris J J Mulder; Adriaan A van Bodegraven; Nanne K H de Boer
Journal:  Inflamm Bowel Dis       Date:  2017-11       Impact factor: 5.325

Review 9.  Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research.

Authors:  Shaocun Zhang; Xiaocang Cao; He Huang
Journal:  Front Cell Infect Microbiol       Date:  2017-02-24       Impact factor: 5.293

10.  Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach.

Authors:  Alessandra Frau; Umer Z Ijaz; Rachael Slater; Daisy Jonkers; John Penders; Barry J Campbell; John G Kenny; Neil Hall; Luca Lenzi; Michael D Burkitt; Marieke Pierik; Alistair C Darby; Christopher S J Probert
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.